BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
NEUROG3
,
glucose metabolic process
,
Diabetes mellitus
,
Liver
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glutamate agonists
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
L-theanine Administration Results in Neuroprotection and Prevents Glutamate Receptor Agonist-Mediate…
Memory defect induced by β-amyloid plus glutamate receptor agonist is alleviated by catalpol and don…
The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced…
An agonist at glutamate and dopamine D2 receptors, LY404039.
Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pomaglumetad Effects on Glutamate Biomarkers
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
Glutamate Reducing Interventions in Schizophrenia
The Influence of Glutamate on Memory in Humans
Metabotropic Receptors For Glutamate Type 3 In Parkinson's
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ